411 related articles for article (PubMed ID: 32786002)
1. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
Evrard P; Henrard S; Foulon V; Spinewine A
J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
[TBL] [Abstract][Full Text] [Related]
2. Use and Deprescribing of Potentially Inappropriate Medications in Frail Nursing Home Residents.
Fournier A; Anrys P; Beuscart JB; Dalleur O; Henrard S; Foulon V; Spinewine A
Drugs Aging; 2020 Dec; 37(12):917-924. PubMed ID: 33047252
[TBL] [Abstract][Full Text] [Related]
3. Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study.
Sibille FX; Spinewine A; Zerah L; Maljean L; Schoevaerdts D; de Saint-Hubert M
BMC Geriatr; 2022 Feb; 22(1):88. PubMed ID: 35100982
[TBL] [Abstract][Full Text] [Related]
4. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
[TBL] [Abstract][Full Text] [Related]
5. Potentially Inappropriate Prescribing in Belgian Nursing Homes: Prevalence and Associated Factors.
Anrys PMS; Strauven GC; Foulon V; Degryse JM; Henrard S; Spinewine A
J Am Med Dir Assoc; 2018 Oct; 19(10):884-890. PubMed ID: 30056012
[TBL] [Abstract][Full Text] [Related]
6. Cluster-Controlled Trial of an Intervention to Improve Prescribing in Nursing Homes Study.
Strauven G; Anrys P; Vandael E; Henrard S; De Lepeleire J; Spinewine A; Foulon V
J Am Med Dir Assoc; 2019 Nov; 20(11):1404-1411. PubMed ID: 31402136
[TBL] [Abstract][Full Text] [Related]
7. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
8. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial.
Cateau D; Ballabeni P; Niquille A
BMC Geriatr; 2021 May; 21(1):289. PubMed ID: 33933030
[TBL] [Abstract][Full Text] [Related]
9. Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial.
Anrys P; Strauven G; Boland B; Dalleur O; Declercq A; Degryse JM; De Lepeleire J; Henrard S; Lacour V; Simoens S; Speybroeck N; Vanhaecht K; Spinewine A; Foulon V
Implement Sci; 2016 Mar; 11():35. PubMed ID: 26968520
[TBL] [Abstract][Full Text] [Related]
10. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
[TBL] [Abstract][Full Text] [Related]
11. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
12. Adaptation and validation of the revised Patients' Attitudes towards Deprescribing (rPATD) questionnaire for benzodiazepine receptor agonists.
Pétein C; Spinewine A; Laroche ML; Niquille A; Henrard S
Res Social Adm Pharm; 2023 Sep; 19(9):1278-1285. PubMed ID: 37301641
[TBL] [Abstract][Full Text] [Related]
13. Potentially Inappropriate Psychotropic Drugs in Nursing Homes: An Italian Observational Study.
Azab M; Novella A; Ianes A; Pasina L
Drugs Aging; 2024 Feb; 41(2):187-197. PubMed ID: 38036916
[TBL] [Abstract][Full Text] [Related]
14. Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria.
Nyborg G; Brekke M; Straand J; Gjelstad S; Romøren M
BMC Geriatr; 2017 Sep; 17(1):220. PubMed ID: 28927372
[TBL] [Abstract][Full Text] [Related]
15. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
[TBL] [Abstract][Full Text] [Related]
16. Balancing medication use in nursing home residents with life-limiting disease.
Paque K; Elseviers M; Vander Stichele R; Pardon K; Vinkeroye C; Deliens L; Christiaens T; Dilles T
Eur J Clin Pharmacol; 2019 Jul; 75(7):969-977. PubMed ID: 30834473
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in Antipsychotic and Benzodiazepine Prescribing Patterns: A Cohort Study of Newly Admitted Nursing Home Residents with Dementia in Ontario, Canada.
Maclagan LC; Maxwell CJ; Harris DA; Campitelli MA; Diong C; Lapane KL; Hogan DB; Rochon P; Herrmann N; Bronskill SE
Drugs Aging; 2020 Nov; 37(11):817-827. PubMed ID: 32978758
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial.
Sibille FX; de Saint-Hubert M; Henrard S; Aubert CE; Goto NA; Jennings E; Dalleur O; Rodondi N; Knol W; O'Mahony D; Schwenkglenks M; Spinewine A
Drugs Aging; 2023 Jun; 40(6):551-561. PubMed ID: 37221407
[TBL] [Abstract][Full Text] [Related]
19. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
Kua CH; Mak VSL; Huey Lee SW
J Am Med Dir Assoc; 2019 Mar; 20(3):362-372.e11. PubMed ID: 30581126
[TBL] [Abstract][Full Text] [Related]
20. Use of Benzodiazepines and Z-Drugs in Nursing Home Residents with Dementia: Prevalence and Appropriateness.
Rijksen DOC; Zuidema SU; de Haas EC
J Alzheimers Dis Rep; 2021; 5(1):871-879. PubMed ID: 35088036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
